Lysosomal storage diseases: Is impaired apoptosis a pathogenic mechanism?

Neurochemical Research

Volumn 29, Issue 5, 2004, Pages 871-880

  Tardy, Claudine ^a   Andrieu Abadie, Nathalie ^a   Salvayre, Robert ^a   Levade, Thierry ^a,b  

^a CHU RANGUEIL   (France)

^b INSERM   (France)

Author keywords

Apoptosis; Cathepsin; Ceramide; Lysosome; Protease; Sphingosine

Indexed keywords

ANTIINFECTIVE AGENT; CATHEPSIN; CERAMIDE; HYDROLASE; PROTEINASE; SPHINGOLIPID;

APOPTOSIS; CELL DEATH; CELL POPULATION; DISEASE EXACERBATION; GENETIC DISORDER; HUMAN; LYSOSOME; LYSOSOME STORAGE DISEASE; NEUROLOGIC DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY; TISSUE INJURY; ENZYMOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVIEW;

APOPTOSIS; ENDOPEPTIDASES; HUMANS; LYSOSOMAL STORAGE DISEASES; LYSOSOMES; SPHINGOLIPIDS;

EID: 3142734904     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NERE.0000021232.05175.38     Document Type: Short Survey

References (106)

1. Winchester, B., Vellodi, A., and Young, E. 2000. The molecular basis of lysosomal storage diseases and their treatment. Biochem. Soc. Trans. 28:150-154.
2. Desnick, R. J. and Schuchman, E. H. 2002. Enzyme replacement and enhancement therapies: lessons from lysosomal disorders. Nat. Rev. Genet. 3:954-966.
3. Jeyakumar, M., Butters, T. D., Dwek, R. A., and Platt, F. M. 2002. Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis. Neuropathol. Appl. Neurobiol. 28:343-357.
4. Wraith, J. E. 2002. Lysosomal disorders. Semin. Neonatol. 7:75-83.
5. Drake, F. H., Dodds, R. A., James, I. E., Connor, J. R., Debouck, C., Richardson, S., Lee-Rykaczewski, E., Coleman, L., Rieman, D., Barthlow, R., Hastings, G., and Gowen, M. 1996. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J. Biol. Chem. 271:12511-12516.
6. Gelb, B. D., Shi, G. P., Chapman, H. A., and Desnick, R. J. 1996. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273:1236-1238.
7. Conzelmann, E. and Sandhoff, K. 1991. Biochemical basis of late-onset neurolipidoses. Dev. Neurosci. 13:197-204.
8. Graber, D., Salvayre, R., and Levade, T. 1994. Accurate differentiation of neuronopathic and nonneuronopathic forms of Niemann-Pick disease by evaluation of the effective residual lysosomal sphingomyelinase activity in intact cells. J. Neurochem. 63:1060-1068.
9. Hengartner, M. O. 2000. The biochemistry of apoptosis. Nature 407:770-776.
10. Wyllie, A. H. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555-556.
11. Rao, L., Perez, D., and White, E. 1996. Lamin proteolysis facilitates nuclear events during apoptosis. J. Cell Biol. 135:1441-1455.
12. Bursch, W. 2001. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ. 8:569-581.
13. Ferri, K. F. and Kroemer, G. 2001. Organelle-specific initiation of cell death pathways. Nat. Cell Biol. 3:E255-263.
14. de Duve, C. 1983. Lysosomes revisited. Eur. J. Biochem. 137:391-397.
15. Johnson, D. E. 2000. Noncaspase proteases in apoptosis. Leukemia 14:1695-1703.
16. Czaja, M. J. 2001. TNF toxicity - death from caspase or cathepsin, that is the question. Hepatology 34:844-846.
17. Leist, M. and Jaattela, M. 2001. Triggering of apoptosis by cathepsins. Cell Death Differ. 8:324-326.
18. Salvesen, G. S. 2001. A lysosomal protease enters the death scene. J. Clin. Invest. 107:21-22.
19. Deiss, L. P., Galinka, H., Berissi, H., Cohen, O., and Kimchi, A. 1996. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J. 15:3861-3870.
20. Roberg, K., Johansson, U., and Ollinger, K. 1999. Lysosomal release of cathepsin D precedes relocation of cytochrome c and loss of mitochondrial transmembrane potential during apoptosis induced by oxidative stress. Free Radic. Biol. Med. 27:1228-1237.
21. Roberts, L. R., Adjei, P. N., and Gores, G. J. 1999. Cathepsins as effector proteases in hepatocyte apoptosis. Cell Biochem. Biophys. 30:71-88.
22. Kagedal, K., Johansson, U., and Ollinger, K. 2001. The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress. FASEB J. 15:1592-1594.
23. Zang, Y., Beard, R. E., Chandraratna, R. A., and Kang, J. X. 2001. Evidence of a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukemia HL-60 cells. Cell Death Differ. 8:477-485.
24. Demoz, M., Castino, R., Cesaro, P., Baccino, F. M., Bonelli, G., and Isidoro, C. 2002. Endosomal-lysosomal proteolysis mediates death signaling by TNFalpha, not by etoposide, in L929 fibrosarcoma cells: evidence for an active role of cathepsin D. Biol. Chem. 383:1237-1248.
25. Takuma, K., Kiriu, M., Mori, K., Lee, E., Enomoto, R., Baba, A., and Matsuda, T. 2003. Roles of cathepsins in reperfusion-induced apoptosis in cultured astrocytes. Neurochem. Int. 42:153-159.
26. Shibata, M., Kanamori, S., Isahara, K., Ohsawa, Y., Konishi, A., Kametaka, S., Watanabe, T., Ebisu, S., Ishido, K., Kominami, E., and Uchiyama, Y. 1998. Participation of cathepsins B and D in apoptosis of PC12 cells following serum deprivation. Biochem. Biophys. Res. Commun. 251:199-203.
27. Roberg, K., Kagedal, K., and Ollinger, K. 2002. Microinjection of cathepsin D induces caspase-dependent apoptosis in fibroblasts. Am. J. Pathol. 161:89-96.
28. Wu, G. S., Saftig, P., Peters, C., and El-Deiry, W. S. 1998. Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity. Oncogene 16:2177-2183.
29. Neuzil, J., Zhao, M., Ostermann, G., Sticha, M., Gellert, N., Weber, C., Eaton, J. W., and Brunk, U. T. 2002. Alpha-tocopheryl succinate, an agent with in vivo anti-tumor activity, induces apoptosis by causing lysosomal instability. Biochem. J. 362:709-715.
30. Reiners, J. J., Jr., Caruso, J. A., Mathieu, P., Chelladurai, B., Yin, X. M., and Kessel, D. 2002. Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves Bid cleavage. Cell Death Differ. 9:934-944.
31. Isahara, K., Ohsawa, Y., Kanamori, S., Shibata, M., Waguri, S., Sato, N., Gotow, T., Watanabe, T., Momoi, T., Urase, K., Kominami, E., and Uchiyama, Y. 1999. Regulation of a novel pathway for cell death by lysosomal aspartic and cysteine proteinases. Neuroscience 91:233-249.
32. Castino, R., Pace, D., Demoz, M., Gargiulo, M., Ariatta, C., Raiteri, E., and Isidoro, C. 2002. Lysosomal proteases as potential targets for the induction of apoptotic cell death in human neuroblastomas. Int. J. Cancer 97:775-779.
33. Tardy, C., Tyynela, J., Hasilik, A., Levade, T., and Andrieu-Abadie, N. 2003. Stress-induced apoptosis is impaired in cells with a lysosomal targeting defect but is not affected in cells synthesizing a catalytically inactive cathepsin D. Cell Death Differ. (in press).
34. Guicciardi, M. E., Deussing, J., Miyoshi, H., Bronk, S. F., Svingen, P. A., Peters, C., Kaufmann, S. H., and Gores, G. J. 2000. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Invest. 106:1127-1137.
35. Guicciardi, M. E., Miyoshi, H., Bronk, S. F., and Gores, G. J. 2001. Cathepsin B knockout mice are resistant to tumor necrosis factor-alpha-mediated hepatocyte apoptosis and liver injury: implications for therapeutic applications. Am. J. Pathol. 159:2045-2054.
36. Foghsgaard, L., Wissing, D., Mauch, D., Lademann, U., Bastholm, L., Boes, M., Elling, F., Leist, M., and Jaattela, M. 2001. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J. Cell Biol. 153:999-1010.
37. Faubion, W. A., Guicciardi, M. E., Miyoshi, H., Bronk, S. F., Roberts, P. J., Svingen, P. A., Kaufmann, S. H., and Gores, G. J. 1999. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J. Clin. Invest. 103:137-145.
38. Levicar, N., Dewey, R. A., Daley, E., Bates, T. E., Davies, D., Kos, J., Pilkington, G. J., and Lah, T. T. 2003. Selective suppression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis. Cancer Gene Ther. 10:141-151.
39. Felbor, U., Kessler, B., Mothes, W., Goebel, H. H., Ploegh, H. L., Bronson, R. T., and Olsen, B. R. 2002. Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Proc. Natl. Acad. Sci. USA 99:7883-7888.
40. Cho, S. and Dawson, G. 2000. Palmitoyl protein thioesterase 1 protects against apoptosis mediated by Ras-Akt-caspase pathway in neuroblastoma cells. J. Neurochem. 74:1478-1488.
41. Cho, S., Dawson, P. E., and Dawson, G. 2000. Antisense palmitoyl protein thioesterase 1 (PPT1) treatment inhibits PPT1 activity and increases cell death in LA-N-5 neuroblastoma cells. J. Neurosci. Res. 62:234-240.
42. Riboni, L., Viani, P., Bassi, R., Prinetti, A., and Tettamanti, G. 1997. The role of sphingolipids in the process of signal transduction. Prog. Lipid Res. 36:153-195.
43. Kolesnick, R. N. and Krönke, M. 1998. Regulation of ceramide production and apoptosis. Annu. Rev. Physiol. 60:643-665.
44. Hannun, Y. A. and Luberto, C. 2000. Ceramide in the eukaryotic stress response. Trends Cell Biol. 10:73-80.
45. Obeid, L. M., Linardic, C. M., Karolak, L. A., and Hannun, Y. A. 1993. Programmed cell death induced by ceramide. Science 259: 1769-1771.
46. Hannun, Y. 1996. Functions of ceramide in coordinating cellular responses to stress. Science 274:1855-1859.
47. Kolesnick, R. and Hannun, Y. A. 1999. Ceramide and apoptosis. Trends Biochem. Sci. 24:224-225.
48. Levade, T., Augé, N., Veldman, R. J., Cuvillier, O., Nègre-Salvayre, A., and Salvayre, R. 2001. Sphingolipid mediators in cardiovascular cell biology and pathology. Circ. Res. 89:957-968.
49. Dbaibo, G. S., Perry, D. K., Gamard, C. J., Platt, R., Poirier, G. G., Obeid, L. M., and Hannun, Y. A. 1997. Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-a: CrmA and Bcl-2 target distinct components in the apoptotic pathway. J. Exp. Med. 185:481-490.
50. Levade, T. and Jaffrézou, J. P. 1999. Signaling sphingomyelinases: which, where, how and why? Biochim. Biophys. Acta 1438:1-17.
51. Igisu, H. and Suzuki, K. 1984. Progressive accumulation of toxic metabolite in a genetic leukodystrophy. Science 224:753-755.
52. Neuenhofer, S., Conzelmann, E., Schwarzmann, G., Egge, H., and Sandhoff, K. 1986. Occurrence of lysoganglioside lyso-GM2 (ll3-Neu5Ac- gangliotriaosylsphingosine) in GM2 gangliosidosis brain. Biol. Chem. Hoppe Seyler 367:241-244.
53. Rosengren, B., Fredman, P., Mansson, J. E., and Svennerholm, L. 1989. Lysosulfatide (galactosylsphingosine-3-O-sulfate) from meta-chromatic leukodystrophy and normal human brain. J. Neurochem. 52:1035-1041.
54. Toda, K., Kobayashi, T., Goto, I., Ohno, K., Eto, Y., Inui, K., and Okada, S. 1990. Lysosulfatide (sulfogalactosylsphingosine) accumulation in tissues from patients with metachromatic leukodystrophy. J. Neurochem. 55:1585-1591.
55. Rodriguez-Lafrasse, C. and Valuer, M. T. 1999. Sphingosylphosphorylcholine in Niemann-Pick disease brain: accumulation in type A but not in type B. Neurochem. Res. 24:199-205.
56. Hannun, Y. A. and Bell, R. M. 1987. Lysosphingolipids inhibit protein kinase C: implications fot the sphingolipidoses. Science 235:670-674.
57. Schissel, S. L., Schuchman, E. H., Williams, K. J., and Tabas, I. 1996. Zn2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene. J. Biol. Chem. 271:18431-18436.
58. Hiraiwa, M., Taylor, E. M., Campana, W. M., Darin, S. J., and O'Brien, J. S. 1997. Cell death prevention, mitogen-activated protein kinase stimulation, and increased sulfatide concentrations in Schwann cells and oligodendrocytes by prosaposin and prosaptides. Proc. Natl. Acad. Sci. USA 94:4778-4781.
59. Campana, W. M., Eskeland, N., Calcutt, N. A., Misasi, R., Myers, R. R., and O'Brien, J. S. 1998. Prosaptide prevents paclitaxel neurotoxicity. Neurotoxicology 19:237-244.
60. Tsuboi, K., Hiraiwa, M., and O'Brien, J. S. 1998. Prosaposin prevents programmed cell death of rat cerebellar granule neurons in culture. Brain Res. Dev. Brain. Res. 110:249-255.
61. Pham, C. T. and Ley, T. J. 1999. Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. Proc. Natl. Acad. Sci. USA 96:8627-8632.
62. Shannon, P., Pennacchio, L. A., Houseweart, M. K., Minassian, B. A., and Myers, R. M. 2002. Neuropathological changes in a mouse model of progressive myoclonus epilepsy: cystatin B deficiency and Unverricht-Lundborg disease. J. Neuropathol. Exp. Neurol. 61:1085-1091.
63. Huang, J. Q., Trasler, J. M., Igdoura, S., Michaud, J., Hanal, N., and Gravel, R. A. 1997. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases. Hum. Mol. Genet. 6:1879-1885.
64. Wada, R., Tifft, C. J., and Proia, R. L. 2000. Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation. Proc. Natl. Acad. Sci. USA 97:10954-10959.
65. Taniike, M., Mohri, I., Eguchi, N., Irikura, D., Urade, Y., Okada, S., and Suzuki, K. 1999. An apoptotic depletion of oligodendrocytes in the twitcher, a murine model of globoid cell leukodystrophy. J. Neuropathol. Exp. Neurol. 58:644-653.
66. Jatana, M., Giri, S., and Singh, A. K. 2002. Apoptotic positive cells in Krabbe brain and induction of apoptosis in rat C6 glial cells by psychosine. Neurosci. Lett. 330:183-187.
67. Tohyama, J., Oya, Y., Ezoe, T., Vanier, M. T., Nakayasu, H., Fujita, N., and Suzuki, K. 1999. Ceramide accumulation is associated with increased apoptotic cell death in cultured fibroblasts of sphingolipid activator protein-deficient mouse but not in fibroblasts of patients with Farber disease. J. Inherit. Metab. Dis. 22:649-662.
68. Coenen, R., Gieselmann, V., and Lullmann-Rauch, R. 2001. Morphological alterations in the inner ear of the arylsulfatase A-deficient mouse. Acta Neuropathol. (Berlin) 101:491-498.
69. Sueyoshi, N., Maehara, T., and Ito, M. 2001. Apoptosis of Neuro2a cells induced by lysosphingolipids with naturally occurring stereochemical configurations. J. Lipid Res. 42:1197-1202.
70. Tohyama, J., Matsuda, J., and Suzuki, K. 2001. Psychosine is as potent an inducer of cell death as C6-ceramide in cultured fibroblasts and in MOCH-1 cells. Neurochem. Res. 26:667-671.
71. Goldin, E., Roff, C. F., Miller, S. P., Rodriguez-Lafrasse, C., Vanier, M. T., Brady, R. O., and Pentchev, P. G. 1992. Type C Niemann-Pick disease: a murine model of the lysosomal cholesterol lipidosis accumulates sphingosine and sphinganine in liver. Biochim. Biophys. Acta 1127:303-311.
72. Wu, Y. P., Kubota, A., and Suzuki, K. 1999. Neuronal death and reactive glial changes in the brain of Niemann-Pick disease type C mouse. Soc. Neurosci. Abstr. 25:1118.
73. Santana, P., Pena, L. A., Haimovitz-Friedman, A., Martin, S., Green, D., McLoughlin, M., Cordon-Cardo, C., Schuchman, E. H., Fuks, Z., and Kolesnick, R. 1996. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86:189-199.
74. de Maria, R., Rippo, M. R., Schuchman, E. H., and Testi, R. 1998. Acidic sphingomyelinase (ASM) is necessary for Fas-induced GD3 ganglioside accumulation and efficient apoptosis of lymphoid cells. J. Exp. Med. 187:897-902.
75. Separovic, D., Pink, J. J., Oleinick, N. A., Kester, M., Boothman, D. A., McLoughlin, M., Pena, L. A., and Haimovitz-Friedman, A. 1999. Niemann-Pick human lymphoblasts are resistant to phthalocyanine 4-photodynamic therapy-induced apoptosis. Biochem. Biophys. Res. Commun. 258:506-512.
76. Komatsu, M., Takahashi, T., Abe, T., Takahashi, I., Ida, H., and Takada, G. 2001. Evidence for the association of ultraviolet-C and H(2)O(2)-induced apoptosis with acid sphingomyelinase activation. Biochim. Biophys. Acta 1533:47-54.
77. Lozano, J., Menendez, S., Morales, A., Ehleiter, D., Liao, W. C., Wagman, R., Haimovitz-Friedman, A., Fuks, Z., and Kolesnick, R. 2001. Cell autonomous apoptosis defects in acid sphingomyelinase knockout fibroblasts. J. Biol. Chem. 276:442-448.
78. Zhang, Y., Mattjus, P., Schmid, P. C., Dong, Z., Zhong, S., Ma, W. Y., Brown, R. E., Bode, A. M., and Schmid, H. H. 2001. Involvement of the acid sphingomyelinase pathway in UVA-induced apoptosis. J. Biol. Chem. 276:11775-11782.
79. Garcia-Ruiz, C., Colell, A., Mari, M., Morales, A., Calvo, M., Enrich, C., and Fernandez-Checa, J. C. 2003. Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice. J. Clin. Invest. 111: 197-208.
80. Farina, F., Cappello, F., Todaro, M., Bucchieri, F., Peri, G., Zummo, G., and Stassi, G. 2000. Involvement of caspase-3 and GD3 ganglioside in ceramide-induced apoptosis in Farber disease. J. Histochem. Cytochem. 48:57-62.
81. Cock, J. G., Tepper, A. D., de Vries, E., van Blitterswijk, W. J., and Borst, J. 1998. CD95 (Fas/APO-1) induces ceramide formation and apoptosis in the absence of a functional acid sphingomyelinase. J. Biol. Chem. 273:7560-7565.
82. Ségui, B., Bezombes, C., Uro-Coste, E., Medin, J. A., Andrieu-Abadie, N., Augé, N., Brouchet, A., Laurent, G., Salvayre, R., Jaffrézou, J. P., and Levade, T. 2000. Stress-induced apoptosis is not mediated by endolysosomal ceramide. FASEB J. 14:36-47.
83. Bezombes, C., Ségui, B., Cuvillier, O., Bruno, A. P., Uro-Coste, E., Gouazé, V., Andrieu-Abadie, N., Carpentier, S., Laurent, G., Salvayre, R., Jaffrézou, J. P., and Levade, T. 2001. Lysosomal sphingomyelinase is not solicited for apoptosis signaling. FASEB J. 15:297-299.
84. Burek, C., Roth, J., Koch, H. G., Harzer, K., Los, M., and Schulze-Osthoff, K. 2001. The role of ceramide in receptor- and stress-induced apoptosis studied in acidic ceramidase-deficient Farber disease cells. Oncogene 20:6493-6502.
85. Haltia, M. 2003. The neuronal ceroid-lipofuscinoses. J. Neuropathol. Exp. Neurol. 62:1-13.
86. Tyynela, J., Sohar, I., Sleat, D. E., Gin, R. M., Donnelly, R. J., Baumann, M., Haltia, M., and Lobel, P. 2000. A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration. EMBO J. 19:2786-2792.
87. Vesa, J. and Peltonen, L. 2002. Mutated genes in juvenile and valiant late infantile neuronal ceroid lipofuscinoses encode lysosomal proteins. Curr. Mol. Med. 2:439-444.
88. Lane, S. C., Jolly, R. D., Schmechel, D. E., Alroy, J., and Boustany, R. M. 1996. Apoptosis as the mechanism of neurodegeneration in Batten's disease. J. Neurochem. 67:677-683.
89. Gupta, P., Soyombo, A. A., Atashband, A., Wisniewski, K. E., Shelton, J. M., Richardson, J. A., Hammer, R. E., and Hofmann, S. L. 2001. Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice. Proc. Natl. Acad. Sci. USA 98: 13566-13571.
90. Nakanishi, H., Zhang, J., Koike, M., Nishioku, T., Okamoto, Y., Kominami, E., von Figura, K., Peters, C., Yamamoto, K., Saftig, P., and Uchiyama, Y. 2001. Involvement of nitric oxide released from microglia-macrophages in pathological changes of cathepsin D-deficient mice. J. Neurosci. 21:7526-7533.
91. Puranam, K., Qian, W. H., Nikbakht, K., Venable, M., Obeid, L., Hannun, Y., and Boustany, R. M. 1997. Upregulation of Bcl-2 and elevation of ceramide in Batten disease. Neuropediatrics 28:37-41.
92. Puranam, K. L., Guo, W. X., Qian, W. H., Nikbakht, K., and Boustany, R. M. 1999. CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide. Mol. Genet. Metab. 66:294-308.
93. Winter, E. and Ponting, C. P. 2002. TRAM, LAG2 and CLN8: members of a novel family of lipid-sensing domains? Trends Biochem. Sci. 27:381-383.
94. Saftig, P., Hetman, M., Schmahl, W., Weber, K., Heine, L., Mossmann, H., Koster, A., Hess, B., Evers, M., von Figura, K., Peters, C. 1995. Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBO J. 14:3599-3608.
95. Rakoczy, P. E., Zhang, D., Robertson, T., Barnett, N. L., Papadimitriou, J., Constable, I. J., and Lai, C. M. 2002. Progressive age-related changes similar to age-related macular degeneration in a transgenic mouse model. Am. J. Pathol. 161:1515-1524.
96. Koike, M., Shibata, M., Ohsawa, Y., Nakanishi, H., Koga, T., Kametaka, S., Waguri, S., Momoi, T., Kominami, E., Peters, C., Figura, K., Saftig, P., and Uchiyama, Y. 2003. Involvement of two different cell death pathways in retinal atrophy of cathepsin D-deficient mice. Mol. Cell Neurosci. 22:146-161.
97. Terman, A., Neuzil, J., Kagedal, K., Ollinger, K., and Brunk, U. T. 2002. Decreased apoptotic response of inclusion-cell disease fibroblasts: a consequence of lysosomal enzyme missorting? Exp. Cell Res. 274:9-15.
98. Simonaro, C. M., Haskins, M. E., and Schuchman, E. H. 2001. Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: a possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses. Lab. Invest. 81:1319-1328.
99. Park, M., Helip-Wooley, A., and Thoene, J. 2002. Lysosomal cystine storage augments apoptosis in cultured human fibroblasts and renal tubular epithelial cells. J. Am. Soc. Nephrol. 13:2878-2887.
100. Tanaka, Y., Guhde, G., Suter, A., Eskelinen, E. L., Hartmann, D., Lullmann-Rauch, R., Janssen, P. M., Blanz, J., von Figura, K., and Saftig, P. 2000. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature 406:902-906.
101. Hersh, B. M., Hartwieg, E., and Horvitz, H. R. 2002. The Caenorhabditis elegans mucolipin-like gene cup-5 is essential for viability and regulates lysosomes in multiple cell types. Proc. Natl. Acad. Sci. USA 99:4355-4360.
102. Riikonen, R., Vanhanen, S. L., Tyynela, J., Santavuori, P., and Tuipeinen, U. 2000. CSF insulin-like growth factor-1 in infantile neuronal ceroid lipofuscinosis. Neurology 54:1828-1832.
103. Zhang, Z., Butler, J. D., Levin, S. W., Wisniewski, K. E., Brooks, S. S., and Mukherjee, A. B. 2001. Lysosomal ceroid depletion by drugs: therapeutic implications for a hereditary neurodegenerative disease of childhood. Nat. Med. 7:478-484.
104. Persaud-Sawin, D. A., VanDongen, A., and Boustany, R. M. 2002. Motifs within the CLN3 protein: modulation of cell growth rates and apoptosis. Hum. Mol. Genet. 11:2129-2142.
105. Seigel, G. M., Lotery, A., Kummer, A., Bernard, D. J., Greene, N. D., Turmaine, M., Derksen, T., Nussbaum, R. L., Davison, B., Wagner, J., and Mitchison, H. M. 2002. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (Batten disease). Mol. Cell. Neurosci. 19:515-527.
106. Pennacchio, L. A., Bouley, D. M., Higgins, K. M., Scott, M. P., Noebels, J. L., and Myers, R. M. 1998. Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice. Nat. Genet. 20:251-258.